GeminIQ Website Logo

Viewing ACTU free

Subscribe for full history, 90+ metrics, screener, watchlist...

ACTUATE THERAPEUTICS, INC.

ACTU

Companies in Pharmaceutical Preparations

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash Equivalents At Carrying Value
81317649140
Prepaid Expense And Other Assets Current
00100110
Assets Current
91417749141
Deferred Costs
-------1
Other Assets Noncurrent
000000--
Assets
91418749142
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
12133226
Other Accrued Liabilities Current
34455667
Convertible Notes Payable Current
-------7
Accrued Salaries Current
11111100
Interest Payable Current
00000000
Liabilities Current
566999820
Liabilities Noncurrent
Other Accrued Liabilities Noncurrent
-----001
Interest Payable Current And Noncurrent
----0000
Accounts Payable Other Current And Noncurrent
----0000
Liabilities Noncurrent
00000002
Liabilities
56710109922
Stockholders Equity
Temporary Equity Carrying Amount Attributable To P…
-----0094
Preferred Stock Value
0000000-
Common Stock Value
00000000
Additional Paid In Capital
1641631611421341321316
Retained Earnings Accumulated Deficit
-160-155-150-145-139-132-126-120
Stockholders Equity
4811-3-505-114
Liabilities And Stockholders Equity
91418749142
Preferred Stock Par Or Stated Value Per Share
0000000-
Preferred Stock Shares Authorized
10101010101010-
Temporary Equity Par Or Stated Value Per Share
-----000
Preferred Stock Shares Issued
0000000-
Temporary Equity Shares Authorized
-----0033
Preferred Stock Shares Outstanding
0000000-
Common Stock Par Or Stated Value Per Share
00000000
Temporary Equity Shares Issued
-----0025
Temporary Equity Shares Outstanding
-----0025
Common Stock Shares Authorized
200200200200200200200267
Common Stock Shares Issued
2423232020202024
Temporary Equity Liquidation Preference
-----00125
Shares Outstanding
2423232020202024

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-35.17%-47.59%----------
2025-8.20%-32.48%-25.61%0.24%-15.09%-18.98%25.00%2.55%-19.90%1.76%15.42%-11.01%
2024---11.35%33.13%32.21%4.56%-2.69%5.49%-7.52%41.34%59.73%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.80
2.39
2.74
0.73
0.46
1.05
1.68
0.03
Quick Ratio
1.72
2.31
2.66
0.71
0.42
0.98
1.59
0.02
Working Capital
3.80M
7.94M
11.07M
-2.51M
-4.91M
405.40K
5.77M
-19.52M
Leverage & Debt
Debt to Equity
1.35
0.77
0.62
-3.63
-1.88
88.44
1.66
-0.19
Interest Coverage TTM
-1,078.36
-1,110.88
-1,268.32
-1,348.98
-1,325.75
-
-
-
Debt Ratio
0.58
0.44
0.38
1.38
2.13
0.99
0.62
12.60
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
-
-
-
Per Share Metrics
Diluted EPS TTM
-0.92
-1.06
-1.52
-1.68
-1.72
-
-
-
Free Cash Flow Per Share TTM
-0.83
-0.91
-0.95
-1.16
-1.36
-
-
-
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
-
-
-
Growth Metrics
Net Income Growth (1Y)
-35.91%
-
-
-
-
-
-
-
EPS Growth (1Y)
-46.91%
-
-
-
-
-
-
-
Valuation Metrics
P/E TTM
-2.99
-5.79
-4.42
-3.64
-3.93
-
-
-
P/B TTM
17.04
16.24
13.09
-45.23
-25.94
639.69
14.98
-
Market Cap
64.49M
128.65M
143.13M
120.04M
132.00M
66.65M
80.26M
-
Enterprise Value
56.36M
115.49M
126.21M
113.55M
128.11M
58.01M
66.73M
-
Calculated Values
Free Cash Flow TTM
-19.60M
-19.21M
-20.24M
-22.71M
-26.46M
-
-
-
Net Debt
-8.13M
-13.16M
-16.92M
-6.49M
-3.89M
-8.64M
-13.52M
6.55M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-01-05Sale
Owner: Thomson, Todd S, Kairos V…
Title: -
Shares: 280,000
Price/Share: $5.80
Value: $1,624,000.00
Shares Owned: 904,795
Relationship: Director,TenPercentOwner
Ownership: Indirect
2025-06-27Purchase
Owner: Bios, Fund Ii, Lp, Bios F…
Title: -
Shares: 71,428
Price/Share: $7.00
Value: $499,996.00
Shares Owned: 196,428
Relationship: Director,TenPercentOwner
Ownership: Indirect
2025-06-27Purchase
Owner: Bios, Equity Cof, Lp, Bio…
Title: -
Shares: 71,428
Price/Share: $7.00
Value: $499,996.00
Shares Owned: 196,428
Relationship: Director,TenPercentOwner
Ownership: Indirect
2025-06-27Purchase
Owner: Bios, Actuate Co-Invest I…
Title: -
Shares: 71,428
Price/Share: $7.00
Value: $499,996.00
Shares Owned: 196,428
Relationship: Director,TenPercentOwner
Ownership: Indirect
2024-08-14Sale
Owner: Bios, Clinical Opportunit…
Title: -
Shares: 24,999
Price/Share: $8.00
Value: $199,992.00
Shares Owned: 131,248
Relationship: Director,TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
58.87%
Inst. Shares: 13,856,355
Shares Outstanding: 23,537,134
2025-12-31
62.32%
Inst. Shares: 13,101,440
Shares Outstanding: 21,021,817
2025-09-30
53.36%
Inst. Shares: 11,415,758
Shares Outstanding: 21,394,965
2025-06-30
56.81%
Inst. Shares: 11,161,522
Shares Outstanding: 19,646,475
2025-03-31
53.35%
Inst. Shares: 10,401,592
Shares Outstanding: 19,497,731

ACTUATE THERAPEUTICS, INC. (ACTU) — SEC Financial Statements & Analysis

ACTUATE THERAPEUTICS, INC. (ACTU) is a pharmaceutical preparations company, incorporated in DE. ACTUATE THERAPEUTICS, INC. trades on Nasdaq as: ACTU. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), ACTUATE THERAPEUTICS, INC. reported a Debt-to-Equity ratio of 1.35x, a Price-to-Book (P/B) ratio of 17.04 (TTM), at a market cap of $64.49M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity
1.35x
P/B TTM
17.04
Market Cap
$64.49M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ACTUATE THERAPEUTICS, INC. in?

ACTUATE THERAPEUTICS, INC. (ACTU) operates in the Pharmaceutical Preparations industry.

What is ACTU's market cap?

ACTUATE THERAPEUTICS, INC. (ACTU) has a market capitalization of $64.49M as of 2026-03-31.

What exchange does ACTU trade on?

ACTUATE THERAPEUTICS, INC. (ACTU) trades on the Nasdaq.

Where is ACTUATE THERAPEUTICS, INC. incorporated?

ACTUATE THERAPEUTICS, INC. is incorporated in DE.

Research Faster.
Invest Smarter.

ACTUATE THERAPEUTICS, INC. (ACTU) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 90+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.